Cite
HARVARD Citation
Coarelli, G. et al. (2022). Safety and efficacy of riluzole in spinocerebellar ataxia type 2 in France (ATRIL): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet neurology. 21 (3), pp. 225-233. [Online].